Gen-Probe Receives European CE Mark For Molecular Test To Detect Common Sexually Transmitted Disease Trichomonas …
Gen-Probe Incorporated (Nasdaq: GPRO) announced that it has received a European CE mark for its APTIMA® assay for Trichomonas vaginalis, a common parasitic sexually transmitted disease. Gen-Probe’s APTIMA Trichomonas assay utilizes the same nucleic acid amplification technologies as the APTIMA COMBO 2® assay, the Company’s market-leading test for chlamydia and gonorrhea, and studies have shown …
Read more on Medical News Today
Popular Posts:
- Know the Truth about the Government Health Care Bill HR 3200-Key Points.flv
- TB Skin Test – Mantoux Method
- Summary Box: Lilly halts Alzheimer’s drug
- Ahead of the Bell: Molecular Insight stock soars
- Ahead of the Bell: Molecular Insight stock soars